Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-22 of 22 for your search:
Drug:
maytansine
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Chemotherapy with Various Schedules of ADR for Soft Tissue and Bone Sarcoma and Mesothelioma
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Completed
Age:
14 to 75
Sponsor:
NCI
Protocol IDs:
EST-3377
2.
Phase I-II Chemotherapy with Maytansine for Solid Tumors and Hematologic Malignancies
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-7608
3.
Phase II Chemotherapy with Maytansine for Acute Leukemia in Children
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
21 and under
Sponsor:
NCI
Protocol IDs:
POG-7819
, MDAR-324
4.
Phase II Chemotherapy with Maytansine for Refractory Solid Tumors
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
SEG-78ST222
, SEG-78ST0102
5.
Phase II Chemotherapy with Maytansine for Malignant Disease
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
DFCI-77015
6.
Phase II Chemotherapy with Maytansine for Advanced Breast Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7809
7.
Phase II Chemotherapy with Maytansine for Advanced Sarcoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7820
8.
Phase II Chemotherapy with Maytansine for Advanced Hodgkin's and non-Hodgkin's Lymphoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7821
9.
Phase II Chemotherapy with Maytansine for Squamous Cell Carcinoma of the Lung
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
UMCC-7708
10.
Phase II Chemotherapy with Maytansine for Advanced Malignant Disease
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
WSU-C-24077
11.
Phase II Evaluation of Maytansine for Unresectable, Recurrent, or Metastatic Islet Cell Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-824401
12.
Phase II Pilot Study of Maytansine in Patients with Hodgkin's and non-Hodgkin's Lymphomas
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
EST-PA-477
13.
Phase II Master Protocol and Chemotherapy with cis-Platinum, Maytansine, or Chlorozotocin for Advanced Small Cell Bronchogenic Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
EST-2578
14.
Phase II Chemotherapy with Maytansine for Advanced Recurrent Pelvic Malignancies
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
GOG-26H
15.
A Master Protocol for Phase II Chemotherapy for Advanced Pancreatic Carcinoma --- SMF (SZC/MITO/5-FU), MTS
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
GITSG-9376B
16.
Phase II Evaluation of Maytansine in Advanced Lung Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-772501
17.
Phase II Chemotherapy with Maytansine or Chlorozotocin for Advanced Breast Cancer with Crossover Upon Progression
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-773202
18.
Phase II Chemotherapy with Maytansine for Advanced Colorectal Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-774601
19.
Phase II Chemotherapy with Maytansine or Streptozotocin for Disseminated Melanoma with Crossover Upon Progression
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-777001A
20.
Phase II Chemotherapy with Maytansine or Chlorozotocin for Disseminated Melanoma with Crossover Upon Progression
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-777001B
21.
Phase II Chemotherapy with CTX/ADR/CACP Followed Upon Failure by Maytansine for Advanced Head and Neck Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-777401
22.
Phase II Chemotherapy with Maytansine for Melanoma and Breast Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-7728
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
